Does DEFERASIROX Cause Disseminated intravascular coagulation? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Disseminated intravascular coagulation have been filed in association with DEFERASIROX (Deferasirox). This represents 0.1% of all adverse event reports for DEFERASIROX.
10
Reports of Disseminated intravascular coagulation with DEFERASIROX
0.1%
of all DEFERASIROX reports
6
Deaths
6
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From DEFERASIROX?
Of the 10 reports, 6 (60.0%) resulted in death, 6 (60.0%) required hospitalization, and 4 (40.0%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEFERASIROX. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does DEFERASIROX Cause?
Death (1,583)
Diarrhoea (993)
Serum ferritin increased (732)
Haemoglobin decreased (615)
Pyrexia (607)
Malaise (605)
Nausea (603)
Sickle cell anaemia with crisis (570)
Vomiting (520)
Pneumonia (494)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which DEFERASIROX Alternatives Have Lower Disseminated intravascular coagulation Risk?
DEFERASIROX vs DEFERIPRONE
DEFERASIROX vs DEFEROXAMINE
DEFERASIROX vs DEFIBROTIDE
DEFERASIROX vs DEFLAZACORT
DEFERASIROX vs DEGARELIX